Laboratorios Farmaceuticos Rovi, S.A. (LON:0ILL)
60.14
+0.34 (0.56%)
At close: Oct 20, 2025
LON:0ILL Revenue
Laboratorios Farmaceuticos Rovi had revenue of 159.70M EUR in the quarter ending June 30, 2025, a decrease of -10.36%. This brings the company's revenue in the last twelve months to 749.00M, down -3.73% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
749.00M EUR
Revenue Growth
-3.73%
P/S Ratio
4.45
Revenue / Employee
340.92K EUR
Employees
2,197
Market Cap
2.86B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
Hikma Pharmaceuticals | 2.35B |
ConvaTec Group | 1.72B |
Spire Healthcare Group | 1.55B |
Genus | 672.80M |
Laboratorios Farmaceuticos Rovi News
- 22 days ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Acquisition Of An Injectable Drug Product Manufacturing Site In Phoenix, Arizona Call (Transcript) - Seeking Alpha
- 22 days ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 3 months ago - Laboratorios Farmaceuticos Rovi, S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Laboratorios Farmaceuticos Rovi SA (WBO:ROVI) Q4 2024 Earnings Call Highlights: Navigating ... - GuruFocus
- 8 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) 2024 Financial Results Earnings Call Transcript - Seeking Alpha